跳至主要内容
临床试验/NCT04130776
NCT04130776已完成不适用

Demonstrating the Stability of the Analytes Measured for 4Kscore: Total PSA (tPSA), Free PSA (fPSA), Intact PSA (iPSA), and Human Kallikrein 2 (hk2) in Clinical Serum Samples Stored Uncentrifuged Before Testing

OPKO Health, Inc.1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2017年10月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
64
试验地点
1
主要终点
fPSA changes in 3 days

研究概览

简要总结

The purpose of the study is to evaluate whether storage of serum uncentrifuged is an allowable preanalytical procedure

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Men capable of donating five 5 mL tubes of whole blood
  • 40 to 80 years old
  • No prior diagnosis of prostate cancer; prior negative prostate biopsy included
  • Total PSA (tPSA) value measured within last year to be: at 1.5 ng/mL to 4 ng/mL, 4.1 ng/mL to 10 ng/mL and 10 ng/mL and above

排除标准

  • In the previous 96 hours (4 days), underwent a digital rectal exam
  • Any invasive urologic procedure in the 6 months prior to study participation
  • Underwent any procedure to treat symptomatic benign prostatic hyperplasia in the last 6 months
  • Radical prostatectomy since tPSA measurement
  • Received within the previous 6 months 5-alpha reductase inhibitor (5-ARI) therapy such as Avodart (dutasteride) or Proscar (finasteride)

结局指标

主要结局

fPSA changes in 3 days

时间窗: Day 0, 1, 2 and 3

Measure fPSA in serum samples at day 0, 1, 2 and 3

hK2 changes in 3 days

时间窗: Day 0, 1, 2 and 3

Measure hK2 in serum samples at day 0, 1, 2 and 3

tPSA changes in 3 days

时间窗: Day 0, 1, 2 and 3

Measure tPSA in serum samples at day 0, 1, 2 and 3

iPSA changes in 3 days

时间窗: Day 0, 1, 2 and 3

Measure iPSA in serum samples at day 0, 1, 2 and 3

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验